Lipid-polymer hybrid nanoparticles in cancer therapy: Current overview and future directions
Cancer remains one of the leading cause of death worldwide. Current therapies are still
ineffective in completely eradicating the disease. In the last two decades, the use of …
ineffective in completely eradicating the disease. In the last two decades, the use of …
Thermo-sensitive chitosan copolymer-gold hybrid nanoparticles as a nanocarrier for delivery of erlotinib
Abstract Here, using (poly (N-isopropylacrylamide)-co-oleic acid)-g-chitosan ((PNIPAAm-co-
OA)-g-CS), CS copolymer-gold hybrid nanoparticles (CGH NPs) were synthesized by …
OA)-g-CS), CS copolymer-gold hybrid nanoparticles (CGH NPs) were synthesized by …
[HTML][HTML] Lipid polymer hybrid nanoparticles as potent vehicles for drug delivery in cancer therapeutics
S Parveen, P Gupta, S Kumar, M Banerjee - Medicine in Drug Discovery, 2023 - Elsevier
Among all diseases, cancer has the highest fatality rate in the world. Conventional therapies
have come a long way, but they still are not a panacea for cancer. Nanotechnology-based …
have come a long way, but they still are not a panacea for cancer. Nanotechnology-based …
[HTML][HTML] Co-delivery of cisplatin and paclitaxel by folic acid conjugated amphiphilic PEG-PLGA copolymer nanoparticles for the treatment of non-small lung cancer
Z He, J Huang, Y Xu, X Zhang, Y Teng, C Huang… - Oncotarget, 2015 - ncbi.nlm.nih.gov
An amphiphilic copolymer, folic acid (FA) modified poly (ethylene glycol)-poly (lactic-co-
glycolic acid)(FA-PEG-PLGA) was prepared and explored as a nanometer carrier for the co …
glycolic acid)(FA-PEG-PLGA) was prepared and explored as a nanometer carrier for the co …
[HTML][HTML] Synergistic combination therapy of lung cancer: Cetuximab functionalized nanostructured lipid carriers for the co-delivery of paclitaxel and 5 …
S Guo, Y Zhang, Z Wu, L Zhang, D He, X Li… - Biomedicine & …, 2019 - Elsevier
Lung cancer remains the leading cause of cancer associated deaths worldwide. Recent
efforts have been focused on combinational and nanoparticulate therapies that can …
efforts have been focused on combinational and nanoparticulate therapies that can …
Metal (Au)-Decorated Chitosan-l-Arginine Polymeric Vector for Codelivery of Gefitinib and miR125b for Lung Cancer Therapy
The progression of lung cancer is highly associated with the aberrant activation of epidermal
growth factor receptor (EGFR) tyrosine kinase and the positive feedback loop between …
growth factor receptor (EGFR) tyrosine kinase and the positive feedback loop between …
Lactoferrin-appended solid lipid nanoparticles of paclitaxel for effective management of bronchogenic carcinoma
Lung cancer is a dreadful disease which claims to be more life threatening as compared to
total sum up of colon, prostate and breast cancers. Thus, there is an urgent need to develop …
total sum up of colon, prostate and breast cancers. Thus, there is an urgent need to develop …
Hyaluronic acid capped, irinotecan and gene co-loaded lipid-polymer hybrid nanocarrier-based combination therapy platform for colorectal cancer
Z Wang, A Zang, Y Wei, L An, D Hong… - Drug Design …, 2020 - Taylor & Francis
Background The current approach for treating colorectal cancer favors the use of drug and
gene combination therapy, and targeted nano-systems are gaining considerable attention …
gene combination therapy, and targeted nano-systems are gaining considerable attention …
Dual polymeric prodrug co-assembled nanoparticles with precise ratiometric co-delivery of cisplatin and metformin for lung cancer chemoimmunotherapy
T Yang, S Yu, L Liu, Y Sun, Y Lan, X Ma, R Zhu… - Biomaterials …, 2020 - pubs.rsc.org
The combination therapy of cisplatin (CDDP) and metformin (MET) is a clinical strategy to
enhance therapeutic outcomes in lung cancer. However, the efficacy of this combination is …
enhance therapeutic outcomes in lung cancer. However, the efficacy of this combination is …
Combination lung cancer chemotherapy: design of a pH-sensitive transferrin-PEG-Hz-lipid conjugate for the co-delivery of docetaxel and baicalin
S Li, L Wang, N Li, Y Liu, H Su - Biomedicine & Pharmacotherapy, 2017 - Elsevier
The aim of the present study is to design a novel dual-ligand lipid based nanoparticle
system. It is conducted by a specific ligand and pH sensitive lipid conjugate. Docetaxel …
system. It is conducted by a specific ligand and pH sensitive lipid conjugate. Docetaxel …